Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD

Inhaled FP500 monotherapy was associated with consistent and clinically important improvements in FEV1, static lung volumes, dynamic operating lung volumes, and exercise endurance when added to established maintenance long-acting bronchodilator therapy in patients with moderate to severe COPD.